Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks

December 15, 2016 1:34 AM UTC

The Cancer Research Society (Montreal, Quebec) named Max Fehlmann president and CEO, effective Jan. 16. He was CEO at the Neomed Institute (Montreal, Quebec).

Cancer company Harpoon Therapeutics Inc. (Cambridge, Mass.) hired Gerald McMahon as president and CEO. He succeeds interim CEO and co-founder Patrick Baeuerle, who will remain a director. McMahon was president and CEO at Kolltan Pharmaceuticals Inc., which Celldex Therapeutics Inc. (NASDAQ:CLDX) acquired...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article